CCL2 and renal fibrosis: The activated NF-κB induce target genes of NF-κB, including ICAM-1 and MCP-1, which in turn enhance inflammation and finally lead to the acceleration of the pathogenesis of glomerulosclerosis and renal fibrosis through ECM accumulation [42].